Clinical trials
Bronchiectasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 4 |
| 2013 | 3 |
| 2014 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 10 |
| Terminated | 7 |
| Unknown status | 2 |
| Suspended | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 4 |
| Boehringer Ingelheim | 4 |
| University of North Carolina, Chapel Hill | 4 |
| Gilead Sciences | 3 |
| Hill-Rom | 2 |
| Insmed Incorporated | 2 |
| International Biophysics Corporation | 2 |
| Mayo Clinic | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Sanofi | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiectasis | 51 |
| Cystic Fibrosis | 11 |
| Pulmonary Disease, Chronic Obstructive | 7 |
| Lung Diseases | 5 |
| Emphysema | 4 |
| Lung Diseases, Interstitial | 3 |
| Pulmonary Fibrosis | 3 |
| Respiratory Tract Diseases | 3 |
| Sarcoidosis | 3 |
| Asthma | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.